NCT06524544 2026-06-02A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerNational Cancer Institute (NCI)Phase 3 Recruiting320 enrolled